STRATUMfiling intelligence๐Ÿ‡ฎ๐Ÿ‡ณ Indian private portal

SABSW

SAB BIOTHERAPEUTICS, INC.
CIK 0001833214 ยท EDGAR โ†—
cleanelevatedtriggeredno dataplanned
77.4
composite ยท 3 signals ยท ELEVATED

Every card below shows the score and the exact filing data it was computed from โ€” no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded โ€” never a guess.

Chat with this filing โ†’

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo โ€” generate one โ†’

Run the bounded investigation agent โ€” reads this company's signals and writes a short, cited summary.

Signals

P-05 ยท FY 2025-12-31 ยท ELEVATED94.0

Tax arbitrage

ETR 0.0% vs 21% statutory โ€” gap persistent across 1 of 1 years
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2026-03-09) โ†—
Evidence โ€” inputs and thresholds
{
  "etr_by_year": {
    "2025-12-31": 0
  },
  "statutory_rate": 0.21,
  "gap_by_year": {
    "2025-12-31": 0.21
  },
  "note": "Low ETR can be fully legitimate; this flags persistence + magnitude for review.",
  "stale": false,
  "latest_filing_period": "2025-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/0001833214-26-000003-index.htm",
    "form": "10-K",
    "filed": "2026-03-09"
  }
}
P-13 ยท FY 2023-12-31 ยท ELEVATED100.0

Zombie / distress

[FY2023 data, stale โ€” no more recent EBIT figure in XBRL] Interest coverage -120.77x below 1.0
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2025-03-31) โ†—
Evidence โ€” inputs and thresholds
{
  "icr_by_year": {
    "2025-12-31": null,
    "2024-12-31": null,
    "2023-12-31": -120.765,
    "2022-12-31": -95.886
  },
  "consecutive_years_below_1": 2,
  "altman_z_double_prime": -0.529,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -38075320,
    "interest_expense_t": 315284
  },
  "stale": true,
  "latest_filing_period": "2025-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1833214/000095017025046994/0000950170-25-046994-index.htm",
    "form": "10-K",
    "filed": "2025-03-31"
  }
}
P-12 ยท FY 2025-12-31 ยท CLEAN10.8

Restatement predictor

F-Score 0.32 โ€” at or below the population base rate
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2026-03-09) โ†—
Evidence โ€” inputs and thresholds
{
  "f_score": 0.324,
  "probability": 0.0012,
  "components": {
    "rsst": 0.535,
    "drec": null,
    "dinv": null,
    "soft": 0.8622,
    "dcs": -1,
    "droa": 0.8485,
    "issue": 0
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2025-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/0001833214-26-000003-index.htm",
    "form": "10-K",
    "filed": "2026-03-09"
  }
}